MedCap AB Financials
| MCAP Stock | SEK 558.00 7.00 1.27% |
MedCap |
Please note, the imprecision that can be found in MedCap AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MedCap AB. Check MedCap AB's Beneish M Score to see the likelihood of MedCap AB's management manipulating its earnings.
MedCap AB Stock Summary
MedCap AB competes with Biotage AB, Invisio Communications, Vitrolife, AddLife AB, and CellaVision. MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0009160872 |
| Business Address | Sundbybergsvgen 1, Solna, |
| Sector | Financial Services |
| Industry | Asset Management |
| Benchmark | Dow Jones Industrial |
| Website | www.medcap.se |
| Phone | 46 8 34 71 10 |
| Currency | SEK - Swedish Kronor |
You should never invest in MedCap AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of MedCap Stock, because this is throwing your money away. Analyzing the key information contained in MedCap AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
MedCap AB Key Financial Ratios
MedCap AB's financial ratios allow both analysts and investors to convert raw data from MedCap AB's financial statements into concise, actionable information that can be used to evaluate the performance of MedCap AB over time and compare it to other companies across industries.| Return On Equity | 0.15 | |||
| Return On Asset | 0.0822 | |||
| Beta | 0.65 | |||
| Z Score | 12.6 |
MedCap Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MedCap AB's current stock value. Our valuation model uses many indicators to compare MedCap AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MedCap AB competition to find correlations between indicators driving MedCap AB's intrinsic value. More Info.MedCap AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for MedCap AB is roughly 1.84 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MedCap AB's earnings, one of the primary drivers of an investment's value.MedCap AB Systematic Risk
MedCap AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MedCap AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on MedCap AB correlated with the market. If Beta is less than 0 MedCap AB generally moves in the opposite direction as compared to the market. If MedCap AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MedCap AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MedCap AB is generally in the same direction as the market. If Beta > 1 MedCap AB moves generally in the same direction as, but more than the movement of the benchmark.
MedCap AB December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MedCap AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MedCap AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of MedCap AB based on widely used predictive technical indicators. In general, we focus on analyzing MedCap Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MedCap AB's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.37 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 11.61 | |||
| Value At Risk | (4.20) | |||
| Potential Upside | 4.34 |
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.